当前位置: X-MOL 学术Diabetes Res. Clin. Pract. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Allergic contact dermatitis in pediatric patients with type 1 diabetes: An emerging issue.
Diabetes Research and Clinical Practice ( IF 6.1 ) Pub Date : 2020-02-19 , DOI: 10.1016/j.diabres.2020.108089
Fortunato Lombardo 1 , Giuseppina Salzano 1 , Giuseppe Crisafulli 2 , Ilenia Panasiti 2 , Angela Alibrandi 3 , Maria Francesca Messina 1 , Giovanni Battista Pajno 2 , Lucia Caminiti 2 , Stefano Passanisi 1
Affiliation  

AIMS Aim of our observational study was to assess the prevalence of allergic contact dermatitis among children and adolescents with type 1 diabetes who use technological devices for diabetes treatment and its management. Secondary outcome was to identify possible clinical and/or demographic variables that could be associated to contact dermatitis. METHODS Among a total of 215 patients using insulin pumps and/or glucose sensors followed-up at our Pediatric Diabetes Centre between January and September 2018, 64 patients were enrolled and 42 (19 male and 23 female) completed the study. Demographic and clinical features of the study population were statistically analysed. All the patients underwent patch testing with specific allergens belonged to resin and acrylate classes. RESULTS Eighteen patients experienced skin reactions suggestive of allergic contact dermatitis, demonstrating a prevalence of 8.4%. None of the demographic or clinical variables were associated to skin reactions. Colophonium was the most identified sensitizing allergen (87.5% of the cases). CONCLUSIONS The rate of sensitization to allergens included into diabetes devices among pediatric patients is higher than commonly assumed. Well-designed studies are needed to better investigate the association between type 1 diabetes and allergic contact dermatitis. Moreover, we suggest that manufactures should supply detailed information about adhesives in order to avoid dermatological complications and consequently a worsening of disease management and patients' quality of life.

中文翻译:

小儿1型糖尿病患者的过敏性接触性皮炎:一个新出现的问题。

目的我们观察性研究的目的是评估使用技术设备进行糖尿病治疗及其管理的1型糖尿病儿童和青少年中过敏性接触性皮炎的患病率。次要结果是确定可能与接触性皮炎相关的临床和/或人口统计学变量。方法在2018年1月至9月间我们的儿科糖尿病中心对215名使用胰岛素泵和/或葡萄糖传感器进行随访的患者中,纳入了64例患者,其中42例(男性19例,女性23例)完成了研究。对研究人群的人口统计学和临床​​特征进行了统计分析。所有接受特定过敏原贴片测试的患者均属于树脂和丙烯酸酯类。结果18例患者出现皮肤反应,提示过敏性接触性皮炎,患病率为8.4%。没有任何人口统计学或临床变量与皮肤反应有关。大棚是最确定的致敏性过敏原(87.5%)。结论小儿患者对糖尿病设备中包含的过敏原的敏感率高于通常的假设。需要进行精心设计的研究,以更好地调查1型糖尿病与过敏性接触性皮炎之间的关联。此外,我们建议制造商应提供有关胶粘剂的详细信息,以免引起皮肤病并发症,从而恶化疾病管理和患者的生活质量。没有任何人口统计学或临床变量与皮肤反应有关。大棚是最确定的致敏性过敏原(87.5%)。结论小儿患者对糖尿病设备中包含的过敏原的敏感率高于通常的假设。需要进行精心设计的研究,以更好地调查1型糖尿病与过敏性接触性皮炎之间的关联。此外,我们建议制造商应提供有关胶粘剂的详细信息,以免引起皮肤病并发症,从而恶化疾病管理和患者的生活质量。没有任何人口统计学或临床变量与皮肤反应有关。大棚是最确定的致敏性过敏原(87.5%)。结论小儿患者对糖尿病设备中包含的过敏原的敏感率高于通常的假设。需要进行精心设计的研究,以更好地调查1型糖尿病与过敏性接触性皮炎之间的关联。此外,我们建议制造商应提供有关胶粘剂的详细信息,以免引起皮肤病并发症,从而恶化疾病管理和患者的生活质量。结论小儿患者对糖尿病设备中包含的过敏原的敏感率高于通常的假设。需要进行精心设计的研究,以更好地调查1型糖尿病与过敏性接触性皮炎之间的关联。此外,我们建议制造商应提供有关胶粘剂的详细信息,以免引起皮肤病并发症,从而恶化疾病管理和患者的生活质量。结论小儿患者对糖尿病设备中包含的过敏原的敏感率高于通常的假设。需要进行精心设计的研究,以更好地调查1型糖尿病与过敏性接触性皮炎之间的关联。此外,我们建议制造商应提供有关胶粘剂的详细信息,以免引起皮肤病并发症,从而恶化疾病管理和患者的生活质量。
更新日期:2020-02-20
down
wechat
bug